Dr. Todd Ovokaitys Biography

Of Baltic descent, Dr. Todd received his MD degree from John Hopkins University Medical School. Specialty training in Internal Medicine was completed at Georgetown University Hospital. He continued with an appointment in the Georgetown system as a Chief Medical Resident, overseeing educational and training programs for interns, residents and medical students in this role. Subspecialty training in Pulmonary and Critical care Medicine was then completed at Georgetown University Hospital. He currently has an appointment at Louisiana State University Health Sciences Institute as an Assistant Professor of Medicine.

In collaboration with Scott Strachan of Edinburgh, Scotland a fundamentally new and powerful laser technology called the Qi Laser has been created. This converts an ordinary laser to a string of impulses that are as rapid as sub-femtosecond. A femtosecond is millionth of a billionth of a second.

As molecules rotate and vibrate at speeds on the order of 10 femtoseconds, the Qi Laser reaches rates that can match and entrain the highest molecular vibration states. Qi Laser Technology thus allows targeted resonance of single bonds or groups of bonds to change the shape, structure, and function of molecules in ways that have not been previously possible. The potential for applications in health wellness, and materials science are very broad.

Perhaps the most notable achievement is the creation of the first new solid state form of aspirin in over a century of research. Especially remarkable is the very high free energy that has been stabilized in this molecule. The practical implication of this discovery is that Aspirin can give faster relief with much smaller doses and few or no side effects. This discovery is now patented worldwide, including the US, China, Taiwan and Japan.

He and his colleague Scott Strachan have also applied their technology to create new forms of cholesterol lowering drugs. With a granted US patent and global patents pending, they have created high free energy forms of all the major statins that reduce production of cholesterol. They have also created two new forms of Zetia, the compound that inhibits absorption of cholesterol. The patent presents 20 new chemical entities that are high free energy forms of a statin or Zetia, either alone or in combination with each other, or within a matrix of high free energy aspirin. The solubility enhancement of using aspirin in the matrix could be as high as 100-fold (the relatively greater solubility of aspirin compared to a statin). The statin-aspirin and statin-aspirin-Zetia combinations are expected to allow lower doses, greater efficacy and fewer side effects. When combined with a suitable regimen of Coenzyme Q10, the side effects of the statins will be predictably mitigated and the therapeutic benefits enhanced.

Dr. Todd has also recently received a granted US patent for the repair of damaged heart tissue. This laser treated nutrient formulation regenerates active myocardial tissue and can reverse the injury of a heart attack in as little as 30 days.

Another body of the work is the relief of the HIV epidemic in Africa. For the past several years, his research group has been providing health enhancing laser activated formulas for programs in South and East Africa. These protocols include exotic rainforest botanicals that strengthen the immune system for wide variety of viral, tubercular and parasitic pathogens. Immune recovery and improved quality of life have been significant.

11 distinct Laser activated nutraceutical formulations have been subjected to controlled clinical trials, all of which have shown multiple statistically significant benefits in the treated persons. Benefits have ranged from general health to enhanced structure and function of specific bodily systems. 2 of these studies have been published in peer-reviewed medical journals thus far, and several others are candidates for publication.

A particularly great area of interest is in rejuvenation technologies. Active areas of research include telomere biology, DNA methylation, and stem cell applications which are the present leading candidates for profound biological regeneration.

Perhaps the most promising of all the applications is laser guided stem cell therapy. The initial in vitro studies at the National Institutes of Health showed a profound ability of the laser to attract stem cells to the beam location.

When stem cells of various sources are injected into the body, the laser gives the instruction to stem cells to migrate to the intended tissue and adhere in that location. Improved condition has been seen within 24 hours in severe heart failure, multiple sclerosis, Parkinson’s, amyotrophic lateral sclerosis, and degenerative joint problems. This compares favorably to the usual 3-6 weeks required to note benefits after typical stem cell therapies without laser activation and guidance. This work has been done in specialty clinics in Salt Lake City, Los Angeles and Orange County. Collaborative research has been invited at UCLA and UCSD and other academic institutions. The potential for pure anti-aging effects is extraordninary.